131 results
6-K
EX-99.1
BLU
Bellus Health Inc
28 Jun 23
GSK completes acquisition of BELLUS Health
11:05am
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more
6-K
EX-99.1
BLU
Bellus Health Inc
16 Jun 23
BELLUS Health Inc. Announces Voting Results from Special Meeting of Shareholders
4:21pm
to vote at the Special Meeting, excluding for this purpose any person required to be excluded pursuant to Multilateral Instrument 61-101 – Protection … for the purpose of entering into the Arrangement agreement and completing the Arrangement. The Purchaser has not carried on any activities to date other than
6-K
EX-99.1
BLU
Bellus Health Inc
6 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:05pm
INVESTOR SERVICES INC., IN THE ENVELOPE PROVIDED FOR THAT PURPOSE. PLEASE REFER TO THE ACCOMPANYING AMENDED AND RESTATED MANAGEMENT INFORMATION CIRCULAR FOR ADDITIONAL PARTICULARS.
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
IT TO THE COMPANY, C/O COMPUTERSHARE INVESTOR SERVICES INC., IN THE ENVELOPE PROVIDED FOR THAT PURPOSE. PLEASE REFER TO THE ACCOMPANYING AMENDED … of the Company or any optionee, for any purpose whatsoever, including, without limitation for the purpose of:
amendments of a “housekeeping” nature, which
6-K
EX-99.3
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
to the Arrangement for the purpose of receiving and transmitting the Consideration to such persons, and receipt of the Consideration by the Depositary … will act as the agent of persons, including the undersigned, who have deposited Shares pursuant to the Arrangement for the purpose of receiving
6-K
EX-99.1
7bnpgcl27zp1zqmcnhe
19 May 23
Current report (foreign)
5:27pm
6-K
EX-99.1
zo6jfj2dfissd
16 May 23
BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition
5:04pm
6-K
EX-99.2
hgru0mh 5zh
27 Apr 23
Material Change Report
6:04am
6-K
EX-99.3
gvr6iyetzxsb6h
27 Apr 23
Material Change Report
6:04am
6-K
EX-99.1
q569cud
18 Apr 23
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
6:02am
6-K
EX-99.2
v2ga qpp2tw3tt8g0
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
6-K
EX-99.1
awz88dd2x2my5w
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
6-K
EX-99.1
ejq6a azyzi
29 Mar 23
Current report (foreign)
5:26pm
SUPPL
qf99456o
14 Nov 22
Supplemental materials (foreign)
5:25pm
6-K
EX-99.1
6ro6h
14 Nov 22
Open Market Sale Agreementsm
5:19pm
F-10
p1kmk8kcc09zaz
26 Aug 22
Registration of securities (Canada)
4:48pm
SUPPL
i42qkv 4h
15 Jul 22
Supplemental materials (foreign)
7:01am
6-K
EX-99.2
2io0v
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm
SUPPL
7uu281h
13 Jul 22
Supplemental materials (foreign)
5:01pm
S-8
EX-5.1
ouolo6kn53y 9b5sadj
19 Apr 22
Registration of securities for employees
4:14pm